Omnio AB, a Umeå-based biotech company focused on innovative treatments for chronic wounds, has secured a major capital injection from current shareholders.
“This support allows us to complete our GMP manufacturing process and move toward clinical trials,” says newly appointed CEO, Felipe Velasquez.
Are you a chemist with a university degree? RegenCura is now hiring to accelerate chemical synthesis and validation testing in their regulatory development work.
Northern Sweden’s only dedicated lab fair is back — and bigger than before. On May 8, Umeå Lab Fair returns to Tvistevägen 48A, bringing together 20 companies under one roof.
“There’s clearly a strong demand — companies have been lining up to take part,” says Christin Grundström, Lab and Community Manager at Umeå Biotech Incubator (UBI).
Umeå-based biotech company Vakona has raised new capital from a combination of existing shareholders and four new private investors. The funds will enable the company to complete the process development of its innovative active substance as it moves toward the clinical phase.
The innovative patch M045A, developed by Mucocort for the treatment of Recurrent Aphthous Stomatitis (commonly known as canker sores), has reached an important milestone with the filing of a new patent application. This latest application focuses specifically on the patch’s unique antimicrobial effect, further strengthening the technology’s intellectual property portfolio.
The Moss Man Daniel Pacurar was part of a Swedish business delegation that visited Thailand, Vietnam and Malaysia. Daniel is part of Umeå Biotech Incubator with Boreal Orchards and the re:moss project, and we contacted Daniel to learn more about the trip.
Roger Folkhage has been appointed as the new CEO of the Umeå-based company Medicvent. He joins from his previous role as Global Sales Director at Bohus Biotech.
Umeå Biotech Incubator (UBI) has been awarded 2.5 million SEK in continued support from Kempestiftelserna for 2026. These funds are designated to assist verification activities for researchers and projects associated with UBI.
Nil Medical’s medical infusion vest, the “Nil Medical Vestpack,” is being tested at five hospitals in Sweden as part of a clinical trial. Now, the company is looking to hire a Business & Sales Manager.
“To achieve our goal of making the vest available to more children and hospitals, we need to grow our team,” says Martin Hanberger, CEO and founder of Nil Medical.
Just weeks after being granted a patent in Australia, Mucocort AB has achieved yet another significant milestone — this time in Japan. The newly approved patent for its innovative mucoadhesive patch, M045A, designed for the treatment of oral aphthous ulcers, further strengthens the company’s global presence.
QureTech Bio AB has been granted a patent by the European Patent Office (EPO) for GmPcides, a new class of synthetic antibacterials.
Umeå-based LIPUM AB has announced the successful completion of their Phase I study with SOL-116, reporting positive results.
Mucocort AB has successfully developed M045A, an innovative mucoadhesive “patch” for the treatment of oral aphthous ulcers. The company has now been granted a patent in Australia for its medical technology innovation, marking a significant milestone in its international expansion.
Lina Olsson, former CEO of HiloProbe, is stepping into a new role as Business Unit Manager at the consulting firm Prevas. The company is expanding into Umeå focusing on MedTech and Life Science.
On Tuesday, 25th Feb, researchers and industry representatives from Umeå’s Life Science sector will come together at Umeå University for Open Up For Innovation, an event designed to foster collaboration and drive innovation.
”A close dialogue between researchers and industry bridges scientific expertise with market needs, driving innovation—ultimately benefiting society through new treatments and solutions,” says Andreas Lindberg and Lisandro Bernardo from Umeå Biotech Incubator, who initiated the event.
Patient Safety Surveillance Solutions (P3S) is developing software that automatically monitors healthcare-associated injuries. Now, Tobias Tovedal, a business coach at Umeå Biotech Incubator (UBI), is stepping in as the new CEO of the Karolinska Institutet (KI) startup.
Dreaming of a career in life sciences? Loïc Talide decided to carve his own path.
A former postdoc at Umeå Plant Science Centre (UPSC), Loïc is now the founder of Labstuce, a company specializing in custom tools and solutions for life science researchers.
“No matter how far this journey takes me, the lessons I’ve learned are invaluable,” Loïc says.
Umeå Biotech Incubator (UBI) has once again been designated as an excellent incubator by the Swedish Innovation Agency, Vinnova and has been awarded SEK 14.6 million in excellence funding, ensuring financial support through 2029.
“This confirms that Vinnova has confidence in our work and our ability to help startups thrive,” says Peter Jacobsson, Acting Head of Operations of UBI.
Umeå has long been identified as a key actor within life science innovation and will soon be highlighted in an exciting new documentary project. Journalist and documentary filmmaker Luis Jachmann visited North Sweden to document Umeå’s role as a life science hub. This marked one holding point in the year-long documentary project, which aims to explore innovative initiatives across Europe and their connection to an integrated European continent.
Dr. Mikael Sellin has been appointed new Board member of QureTech Bio AB to represent the major investor, Kempestiftelserna.